Control of Rheumatic Fever: How Are We Doing?

作者: Edward A. Mortimer

DOI: 10.1001/JAMA.1977.03270430062023

关键词: Penicillin G BenzathineGroup AMedicineImmunologyInternal medicineAcute rheumatic feverStreptococcusRecurrent rheumatic feverHeart diseaseErythromycinRheumatic fever

摘要: The American Heart Association has recently published updated recommendations for the prevention of acute rheumatic fever. 1 These are essentially same as those first 24 years ago 2 ; major differences a consequence development injectable penicillin G benzathine and erythromycin, demonstration that group A streptococci frequently exhibit resistance to tetracyclines. similarities indicate there have been very few changes in our approach control heart disease since it was shown fever can be averted by appropriate treatment inciting streptococcal infection recurrent prevented continuous prophylaxis. We still do not know how predict among with infections who at risk fever, distinguish carriers from actual except retrospect, or exactly Streptococcus

参考文章(4)
K A Conrad, B L Molk, C A Chidsey, Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation. ,vol. 55, pp. 1- 7 ,(1977) , 10.1161/CIRC.55.1.1/B
MILTON MARKOWITZ, Eradication of Rheumatic Fever An Unfulfilled Hope Circulation. ,vol. 41, pp. 1077- 1084 ,(1970) , 10.1161/01.CIR.41.6.1077
ROBERT W. QUINN, EPIDEMIOLOGIC STUDY OF SEVEN HUNDRED AND FIFTY-SEVEN CASES OF RHEUMATIC FEVER Archives of Internal Medicine. ,vol. 80, pp. 709- 727 ,(1947) , 10.1001/ARCHINTE.1947.00220180014002
Kuttner A, Bellows Mt, Rammelkamp Ch, Breese Bb, Massell Bf, Schlesinger Er, Fischel Ee, Prevention of rheumatic fever. Circulation. ,vol. 7, pp. 316- ,(1953)